Monitoring Exhaled Breath to Noninvasively Detect Glycemic Events

Recruiting N/A Interventional Study
Diabetes Hyperglycemia Hypoglycemia
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
12 – 19
Sex
Any
Study type
Interventional
Purpose
Diagnostic
Participants needed
30 (estimated)
Sponsor
Indiana University · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The purpose of this study is to determine whether an array of biosensors can noninvasively identify hyperglycemic or hypoglycemic events in persons diagnosed with diabetes through noninvasive detection of volatile organic compounds in exhaled breath.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Who are diagnosed with type 1 diabetes. * Who are between 12-19 years of age. * That utilize a Dexcom (G6 or G7) continuous glucose monitoring device. * That have an established working CGM for at least 12 hours (that does not need to be replaced within 24 hours). * That are w…
Contacts

Mangilal Agarwal, PhD

317-278-9792

agarwal@iupui.edu

CONTACT

Mark D Woollam, PhD

267-249-4787

mwoollam@iu.edu

CONTACT